@article{fdi:010076087,
  title = {{I}ntimate partner violence against {HIV}-positive {C}ameroonian women : prevalence, associated factors and relationship with antiretroviral therapy discontinuity-results from the {ANRS}-12288 {EVOLC}am survey},
  author = {{F}iorentino, {M}arion and {S}agaon {T}eyssier, {L}uis and {N}diaye, {K}. and {S}uzan-{M}onti, {M}. and {M}engue, {M}. {T}. and {V}idal, {L}aurent and {K}uaban, {C}. and {M}arch, {L}aura and {L}aurent, {C}hristian and {S}pire, {B}. and {B}oyer, {S}. and {L}i{\'e}geois, {F}lorian and {E}ymard {D}uvernay, {S}abrina and {EVOLC}am {S}tudy {G}roup},
  editor = {},
  language = {{ENG}},
  abstract = {{B}ackground: {I}ntimate partner violence in its various forms increases {HIV} exposure in female victims and potentially jeopardizes the {HIV} treatment cascade, for instance, by impeding engagement in and adherence to care. {E}levated rates of {HIV} and intimate partner violence are reported in {C}entral {A}frica. {E}vidence on the effect of intimate partner violence on antiviral therapy interruption is lacking in {C}ameroon, where only 330,000 women live with {HIV} and only 19% of {HIV}-positive people are virally suppressed. {T}his study aimed to assess the prevalence and factors of intimate partner violence against {HIV}-positive women and its relationship with antiretroviral therapy interruption > 1 month. {M}ethods: {T}he {EVOLC}am cross-sectional survey was conducted in 19 hospitals in the {C}enter and {L}ittoral regions. {T}he study sample comprised antiviral therapy-treated women declaring at least one sexual partner in the previous year. {S}cores of recent emotional, physical, extreme physical and sexual intimate partner violence were built using principal component analysis and categorized under no, occasional or frequent intimate partner violence. {M}ultivariate logistic analyses were performed to investigate the relationship between intimate partner violence and recent antiretroviral therapy interruption > 1 month, and associated factors. {R}esults: {A}mong the 894 analyzed women, the prevalence of intimate partner violence was 29% (emotional), 22% (physical), 13% (extreme physical) and 18% (sexual). {F}requent physical intimate partner violence was a significant risk factor of antiretroviral therapy interruption > 1 month (adjusted odds ratio = 2.42 (95% confidence interval = 1.00; 5.87)). {I}t was also associated with {HIV}-related stigma (2.53 (1.58; 4.02)), living with a main partner (2.03 (1.20; 3.44) and non-defensive violence against this partner (5.75 (3.53; 9.36)). {C}onclusion: {I}ntimate partner violence is a potential barrier to antiviral therapy continuity and aggravates vulnerability of {C}ameroonian {HIV}-positive women. {T}he prevention and detection of intimate partner violence by {HIV} services might help to reach the last "90" of the 90-90-90 targets.},
  keywords = {antiretroviral therapy interruption ; {C}ameroon ; {HIV} ; intimate partner ; violence ; women ; {CAMEROUN}},
  booktitle = {},
  journal = {{W}omens {H}ealth},
  volume = {15},
  numero = {},
  pages = {1--12},
  ISSN = {1745-5057},
  year = {2019},
  DOI = {10.1177/1745506519848546},
  URL = {https://www.documentation.ird.fr/hor/fdi:010076087},
}